The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome

Pediatric Nephrology

Volumn 18, Issue 9, 2003, Pages 919-924

  Abeyagunawardena, Asiri S ^a   Dillon, Michael J ^a   Rees, Lesley ^a   van't Hoff, William ^a   Trompeter, Richard S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Corticosteroid; Nephrotic syndrome; Relapse; Remission; Steroid sensitive; Steroid sparing

Indexed keywords

ALKYLATING AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOMODULATING AGENT; LEVAMISOLE; PENICILLIN G; PREDNISOLONE; STEROID; VINCRISTINE;

ARTICLE; BEHAVIOR DISORDER; BONE DISEASE; CATARACT; CHILDHOOD DISEASE; COHORT ANALYSIS; COMPLICATION; CONTROLLED STUDY; CUSHING SYNDROME; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG POTENCY; DRUG USE; FREQUENCY ANALYSIS; GROWTH RETARDATION; HUMAN; HUMAN TISSUE; HYPERTENSION; LEUKOPENIA; MAJOR CLINICAL STUDY; MEDICAL RECORD; NEPHROTIC SYNDROME; NEPHROTOXICITY; NEUTROPENIA; OBESITY; PATIENT REFERRAL; PEDIATRIC HOSPITAL; PRESCRIPTION; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; STRIA; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; NEPHROTIC SYNDROME; PREDNISOLONE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0141523255     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1216-z     Document Type: Article

References (34)

1. Koskimes O (1982) Long term outlook of primary nephrotic syndrome. Arch Dis Child 57:544-548
2. Trompeter RS, Lloyd BW, Hicks J, White RH, Cameron JS (1985) Long-term outcome for children with minimal change nephrotic syndrome. Lancet I:368-370
3. Hoyer PF, Gonda S, Barthels M, Krohn HP, Brodehl J (1986) Thromboembolic complications in children with nephrotic syndrome. Risk and incidence. Acta Paediatr Scand 75: 804-807
4. Kresnsky AM, Ingelfinger JR, Grupe WE (1982) Peritonitis in childhood nephrotic syndrome. Am J Dis Child 136:732-736
5. Ehrich JH, Brodehl J (1993) Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children (Arbeitsgemeinschaft für Pädiatrische Nephrologie). Eur J Pediatr 150:380-387
6. Brodehl J (1991) Conventional therapy for idiopathic nephrotic syndrome in children. Clin Nephrol 35 [Suppl 1]: S8-S15
7. Trompeter RS (1989) Immunosuppressive therapy in nephrotic syndrome in children. Pediatr Nephrol 3:218-220
8. Latta K, Schnakenburg C von, Ehrich JH (2001) A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children Pediatr Nephrol 16:271-282
9. Consensus statement on management and audit potential for steroid responsive nephrotic syndrome (1994) Report of a workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians. Arch Dis Child 70:151-157
10. Neuhaus TJ, Fay J, Dillon MJ, Trompeter RS, Barratt TM (1994) Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome. Arch Dis Child 71: 522-526
11. Trompeter RS (1986) Minimal change nephrotic syndrome and cyclophosphamide. Arch Dis Child 61:727-729
12. International Study of Kidney Disease in Children (1982) Early identification of frequent relapsers among children with minimal change nephrotic syndrome. J Pediatr 101:514-518
13. Bouissou F, Meissner I, Konrad M, Sommer E, Mytilineos J, Ohayon E, Sierp G, Barthe B, Opelz G, Cambon-Thomsen A, et al (1995) Clinical implications from studies of HLA antigens in idiopathic nephrotic syndrome in children. Clin Nephrol 44:279-283
14. Zidar N, Avgustin CM, Kenda RB, Ferluga D (1998) Unfavorable course of minimal change nephrotic syndrome in children with intrauterine growth retardation Kidney Int 54:1320-1323
15. Kabuki N, Okugawa T, Hayakawa H, Tomizawa S, Kasahara T, Uchiyama M (1998) Influence of age at onset on the outcome of steroid-sensitive nephrotic syndrome. Pediatr Nephrol 12:467-470
16. Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet II:556-560
17. Hulton SA, Shah V, Byrne MR, Morgan G, Barratt TM, Dillon MJ (1994) Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr Nephrol 8:135-139
18. Topaloglu R, Saatci U, Arikan M, Canpinar H, Bakkaloglu A, Kansu E (1994) T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome. Pediatr Nephrol 8:649-652
19. Trompeter RS, Layward L, Hayward AR (1978) Primary and secondary abnormalities of T cell sub populations. Clin Exp Immunol 34:388-392
20. Yap H, Cheung W, Murugasu M, Sim S, Seah C Jordon SC (1999) Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 10:529-537
21. Durkan AM, Hodson EM, Willis NS, Craig JC (2001) Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomised controlled trials. Kidney Int 59: 1919-1927
22. Barratt TM, Bercowsky A, Osofsky SG, Soothill JF (1975) Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood. Lancet 1:55-58
23. Etteldorf JN, West CD, Pitcock JA, Williams DL (1976) Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome. J Pediatr 88:206-212
24. Fu LS, Chi CS (2000) Levamisole in steroid-sensitive nephrotic syndrome children with steroid-dependency and/or frequent relapses. Acta Paediatr Taiwan 41:80-84
25. British Association for Paediatric Nephrology (1991) Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 337:1555-1557
26. Bagga A, Hari P (2000) Levamisole-induced vasculitis. Pediatr Nephrol 14:1057-1058
27. Bulugahapitiya DT (1997) Liver toxicity in a nephrotic patient treated with levamisole. Arch Dis Child 76:289
28. Ginevri F, Trivelli A, Ciardi MR, Ghiggeri GM, Parfumo F, Gusmano R (1996) Protracted levamisole in children with frequent-relapse nephrotic syndrome. Pediatr Nephrol 10:550
29. Brodehl J (1996) Management of nephrotic syndrome in children. Clin Immunother 5:175-192
30. Bia MJ, Flye W (1984) Lymphoma and cyclosporin. Lancet I:1408
31. Walker RJ, Tiller DJ, Horvath JS, Duggin GG (1989) Malignant lymphoma in a renal transplant patient on cyclosporin A therapy. Aust N Z J Med 19:154-155
32. Grupe WE, Makker SP, Ingelfinger JR (1976) Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med 295:746-749
33. Mees EJH (1996) Does it make sense to administer albumin to the patient with nephrotic oedema. Nephrol Dial Transplant 11:1224-1225
34. Haws RM, Baum M (1993) Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics 91: 1142-1146